Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 24501-24550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06719596
Probiotics Combined with Enteral Nutrition Reduces Postoperative Infectious Complications in PD
PHASE1/PHASE2Recruiting
68 participants
Started: May 10, 2024 · Completed: Jun 28, 2025
1 condition1 sponsor1 location
NCT06413992
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
PHASE2Recruiting
117 participants
Started: May 10, 2024 · Completed: Jun 1, 2027
3 conditions1 sponsor1 location
NCT06653998
Feasibility and Safety of Early Mobilization and Rehabilitation in Intensive Care Unit Patients
N/ARecruiting
220 participants
Started: May 10, 2024 · Completed: Apr 30, 2025
2 conditions1 sponsor4 locations
NCT06496399
Evaluation of the Psychoeducation Program Given to the Elderly Living Alone at Home in Terms of Some Parameters
NARecruiting
48 participants
Started: May 10, 2024 · Completed: Jun 29, 2025
1 condition1 sponsor1 location
NCT06421831
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
PHASE1/PHASE2Recruiting
21 participants
Started: May 10, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06411678
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
EARLY_PHASE1Recruiting
50 participants
Started: May 10, 2024 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06398561
Peer-led Intervention for Individuals With Major Depression.
NARecruiting
70 participants
Started: May 10, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06524726
The International PNH Interest Group PNH Registry
N/ARecruiting
2,000 participants
Started: May 10, 2024 · Completed: May 10, 2029
1 condition1 sponsor1 location
NCT04945148
Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PHASE2Recruiting
640 participants
Started: May 10, 2024 · Completed: May 31, 2028
1 condition2 sponsors7 locations
NCT06100055
The ReVo Study: Low-volume vs High-volume Rectal Irrigation
NARecruiting
166 participants
Started: May 10, 2024 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT06547372
Dietary Intervention on Atopy
NARecruiting
60 participants
Started: May 10, 2024 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT06410378
s Serratus Anterior Block for Perioperative Analgesia
NARecruiting
75 participants
Started: May 10, 2024 · Completed: Aug 1, 2024
2 conditions1 sponsor1 location
NCT06349473
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
PHASE1Recruiting
36 participants
Started: May 10, 2024 · Completed: Apr 27, 2026
4 conditions1 sponsor10 locations
NCT05685199
Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
N/ARecruiting
150 participants
Started: May 10, 2024 · Completed: Mar 31, 2030
3 conditions2 sponsors1 location
NCT06937853
Effect of Genetic Polymorphisms on Response to Preoperative NSAIDs in Endodontic Postoperative Pain Management
NARecruiting
200 participants
Started: May 10, 2024 · Completed: Aug 3, 2025
1 condition1 sponsor1 location
NCT06315179
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
N/ARecruiting
200 participants
Started: May 10, 2024 · Completed: Jan 31, 2030
12 conditions2 sponsors1 location
NCT05663034
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
NARecruiting
360 participants
Started: May 10, 2024 · Completed: Sep 30, 2026
10 conditions2 sponsors5 locations
NCT06239298
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
PHASE1/PHASE2Recruiting
130 participants
Started: May 10, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06499051
Epidemiology of French Sexual Offenders. A Cross-sectional Study
N/ARecruiting
400 participants
Started: May 10, 2024 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT06396897
Hospital @ Home Model of Care for Cirrhosis
NARecruiting
30 participants
Started: May 10, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06405997
The Genotype and Phenotype of Lymphangioleiomyomatosis
N/ARecruiting
100 participants
Started: May 10, 2024 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT05793294
Child Health, Nutrition and Microbiome Development
N/ARecruiting
70 participants
Started: May 10, 2024 · Completed: May 31, 2026
5 conditions5 sponsors2 locations
NCT05233527
Novosyn® Quick in Patients Undergoing Episiotomy Closure
N/ARecruiting
300 participants
Started: May 9, 2024 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06708234
Frequency of Isthmocele Following Single- Vs Double-layer Uterine Closure.
N/ARecruiting
200 participants
Started: May 9, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06298058
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
PHASE1Recruiting
144 participants
Started: May 9, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06195605
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
NARecruiting
15 participants
Started: May 9, 2024 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT06805253
Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation
N/ARecruiting
120 participants
Started: May 9, 2024 · Completed: May 31, 2030
6 conditions2 sponsors2 locations
NCT06425926
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
117 participants
Started: May 9, 2024 · Completed: Nov 30, 2026
2 conditions1 sponsor11 locations
NCT06414083
Histologic Comparison of Ablative Techniques for Endometriosis
NARecruiting
141 participants
Started: May 9, 2024 · Completed: Jun 9, 2025
4 conditions1 sponsor1 location
NCT06312020
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome
PHASE2Recruiting
262 participants
Started: May 9, 2024 · Completed: Feb 9, 2027
1 condition1 sponsor67 locations
NCT06314009
Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During Pregnancy
N/ARecruiting
30 participants
Started: May 9, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06462313
Dobutamine for Management of Surgical Patients with Septic Shock
NARecruiting
584 participants
Started: May 9, 2024 · Completed: Apr 30, 2027
3 conditions44 sponsors1 location
NCT06414044
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
N/ARecruiting
100 participants
Started: May 9, 2024 · Completed: Apr 30, 2026
4 conditions18 sponsors2 locations
NCT05703971
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
PHASE1/PHASE2Recruiting
62 participants
Started: May 9, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor17 locations
NCT06369584
Prone Position During ECMO in Pediatric Patients With Severe ARDS
NARecruiting
7 participants
Started: May 9, 2024 · Completed: Jul 1, 2025
2 conditions8 sponsors8 locations
NCT06413823
Prevention and Treatment of Cardiovascular Disease
N/ARecruiting
218 participants
Started: May 9, 2024 · Completed: May 13, 2026
1 condition1 sponsor1 location
NCT06856941
CsDCS on Functional Mobility in Parkinsons Disease
NARecruiting
66 participants
Started: May 9, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06283212
A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome
PHASE1/PHASE2Recruiting
4 participants
Started: May 9, 2024 · Completed: Sep 30, 2030
1 condition1 sponsor3 locations
NCT06056102
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
PHASE1Recruiting
20 participants
Started: May 9, 2024 · Completed: Dec 15, 2042
3 conditions2 sponsors3 locations
NCT06218706
LIFU for Treatment for Refractory Opioid Use Disorder
NARecruiting
34 participants
Started: May 9, 2024 · Completed: Mar 1, 2028
1 condition2 sponsors1 location
NCT06457841
Stress and Resilience
NARecruiting
456 participants
Started: May 9, 2024 · Completed: Jul 31, 2027
2 conditions2 sponsors2 locations
NCT07203612
Tailoring a Home Supervision Intervention for Latinx Caregivers
NARecruiting
100 participants
Started: May 9, 2024 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT06646809
Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial
PHASE3Recruiting
80 participants
Started: May 9, 2024 · Completed: Dec 31, 2024
1 condition2 sponsors4 locations
NCT06310278
Ossiview Normative Mobility Data Collection Protocol
N/ARecruiting
120 participants
Started: May 9, 2024 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT06369857
Pectopexy for Apical Prolapse Management
NARecruiting
10 participants
Started: May 9, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06326983
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
NARecruiting
58 participants
Started: May 9, 2024 · Completed: Apr 1, 2026
6 conditions1 sponsor1 location
NCT06546397
Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
PHASE1Recruiting
200 participants
Started: May 9, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06439576
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
N/ARecruiting
1,000 participants
Started: May 9, 2024 · Completed: Nov 30, 2027
3 conditions2 sponsors6 locations
NCT06436677
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
N/ARecruiting
100 participants
Started: May 9, 2024 · Completed: Dec 31, 2030
2 conditions3 sponsors3 locations
NCT06223269
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
PHASE3Recruiting
50 participants
Started: May 9, 2024 · Completed: Jan 31, 2026
5 conditions2 sponsors4 locations